Patent applications published 19 May 2010
Selected patent applications from the weekly European Patents Bulletin
- Pyridine carboxamide orexin receptor antagonists
Merck Sharp & Dohme 2184981*
- Oral cannbinoid liquid formulations and methods of treatment
Insys Therapeutics 2184983*
- Derivatives of N-(arylamino) sulphonamides including polymorphs as inhibitors of MEK as well as compsns, methods of use and methods for preparing the same
Ardea Biosciences 2184984*
- Pharmaceutical compsns for treating chronic pain and pain associated with neuropathy
Trinity Laboratories 2184986*
- Bi-dentate compounds as kinase inhibitors
Burnham Institute for Medical Research 2184987*
- Small molecule inhibitors of LCK SH2 domain binding
University of Maryland 2184988*
- Compsns and methods for controlling nematodes
Divergence 2184989*
- 3’-substituted compounds having 5-HT6 receptor affinity
Memory Pharmaceuticals 2184990*
- Heterocycle-arul compounds for inflammation and immune-related uses
Synta Pharmaceuticals 2184994*
- Composites for biomedical applications
University of Massachusetts Medical School 2184995*
- Methods of treating blood cell depletion
Immuneregen Biosciences 2184996*
- Diagnostic and treatment methods for characterising bacterial microbiota in skin conditions
New York University 2184997*
- Tablet containing donepezile hydrochloride in amorphous form
Zhejiang Huahai Pharmaceutical; Alfred E Tiefenbacher 2185130*
- Continuous process for microspheres production by using expanded fluids
Universita’ Degi Studi di Salerno 2185131*
- Colour-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
CeloNova Biosciences 2185132*
- Calcium phosphate microspheres drug delivery system and process for preparing the same
Hans Biomed 2185133*
- Device for the oral administration of active principles
Unither Developpement 2185134*
- Non-aggregating virus formulation
Ark Therapeutics 2185135*
- Oral calcitonin compsns and applications thereof
Novartis 2185136*
- Carrier-free orodispersible and/or dispersible solid compsn with noticeable effect and method for preparing same
Galenix Innovations 2185137*
- Solid preparation comprising alogliptin and metformin hydrochloride
Takeda Pharmaceutical Company 2185138*
- Bupropion hydrobromide and therapeutic applications
Biovail Laboratories International 2185139*
- Compsns for manufacturing orally disintegrating dosage form to protect coating layer of active substance
Choongwae Pharma 2185140*
- A combination treatment
Orion 2185141*
- Antiseptics
Insight Health 2185142*
- Antimicrobial parenteral formulation
Taigen Biotechnology 2185143*
- Compsn for prevention or treatment of bone metabolism disorder comprising D-pinitol as an active ingredient
Solgent 2185144*
- Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection
Board of Trustees of the University of Arkansas 2185145*
- Pharmaceutical compsns for intranasal administration comprising choline salts of succinic acid
Buddha Biopharma 2185146*
- Intranasal pharmaceutical compsns comprising succinic acid and methods thereof
Buddha Biopharma 2185147*
- Use of travoprost for treating hair loss
Galderma Research & Development 2185148*
- Use of KNCQ potassium channel openers for reducing symptoms of or treating disorders or conditions wherein the dopaminergic system is disrupted
H Lundbeck 2185149*
- Use of tranilast and derivatives thereof for the therapy of neurological conditions
Syngis Bioscience 2185150*
- Anti-inflammatory compsn
Cambridge Enterprise 2185151*
- Alpha7 NACHR agonists for treating or preventing metabolic disorders
Targacept; Medical College of Georgia Research Institute 2185152*
- Inhibitors of intracellular urokinase plasminogen activator and methods of use thereof
The Regents of the University of California 2185153*
- Method of treating CXCR3 mediated diseases using heterocyclic substituted piperazines
Schering; Pharmacopeia 2185154*
- Pharmaceutical compsn containing dopamine receptor ligands and methods of treatment using dopamine receptor ligands
Forest Laboratories Holdings; Richter Gedeon 2185155*
- Treatments and prevention of hydrocephalus
The University of Manchester 2185156*
- DHEA compsns for treating menopause
Endorecherche 2185157*
- Use of phosphatidylcholine for treating steroid-dependent and steroid-refractory ulcerative cholitis
Stremmel, Wolfgang 2185158*
- Bortezomib and process for producing same
Dr Reddy’s Laboratories Ltd; De Reddy’s Laboratories Inc 2185159*
- Method of providing patient specific immune response in amyloidoses and protein aggregation disorders
Neurimmune Therapeutics 2185160*
- Silica-based nanoparticles and methods of stimulating bone formation and suppressing bone resorption through modulation of NF-KB
Emory University 2185161*
- Polymer therapy for the treatment of chronic microvascular diseases
Synthrx 2185162*
- Method and compound for the treatment of articular diseases or articular pain, or for the treatment of skin for aesthetic or other purposes, and the method of preparation of the compound
Biotechnology Institute 2185164*
- Compsn and therapeutic anti-tumour vaccine
Erytech Pharma 2185164*
- Methods of generating, repairing and/or maintaining connective tissue in vivo
Angioblast Systems 2185165*
- Process for preparing a plant extract of Passiflora alata and use of said extract in cosmetic and pharmaceutical compsns
Natura Cosméticos; Universidade Federal de Santa Catarina 2185166*
- Sytem and method for assessing traditional medicines
Leung, Albert; Pennyroyal, Greg 2185167*
- Method for preparing a hypericum extract in neem oil and a substance so obtained
Moses SRL 2185168*
- Use of vitex agnus castus extracts for preparing a medicament
Max Zeller Söhne 2185169*
- Compsn for long-acting peptide analogues
PharmaIN 2185170*
- Use of neurotrophic factor for retinal cholinergic neurons (NRFCM) and chorionic gonadotropin-beta (109-145) as therapeutic agents
Mondobiotech Laboratories 2185171*
- Use of follicular gonadotropin releasing peptide as a therapeutic agent in the treatment of streptococcus pnemoniae infection
Mondobiotech Laboratories 2185172*
- Use of phosphatases to treat neuroblastomas and medullagastromas
Lixte Biotechnology; The Government of the United States, as represented by the Secretary of Health and Human Services 2185173*
- Use of TRIM72 as a target for muscle and heart enhancer
Korea University Industrial and Academic Collaborative Foundation 2185174*